Novel Skp1 inhibitor has potent preclinical efficacy against castration-resistant prostate cancer.
Li X, Mamouni K, Zhao R, Bai L, Chen Y, Wu Y, Xie ZR, Sautto GA, Liu D, Bowen NJ, Danaher A, Li D, Cook N, Grayson S, Zhu J, Coleman IM, Nelson PS, Bao Q, Zhou J, Osunkoya AO, Kucuk O, Gera L, Wu D.
Li X, et al.
Br J Cancer. 2025 Jun;132(12):1188-1199. doi: 10.1038/s41416-025-02993-8. Epub 2025 Apr 19.
Br J Cancer. 2025.
PMID: 40253488